Specificity of a commercial indirect immunofluorescence technique in the diagnosis of visceral leishmaniasis in patients infected with HIV-1. 1996

J A Gallardo, and J A Pineda, and J Macías, and R Torronteras, and E Lissen
Viral Hepatitis and AIDS Study Group, Virgen del Rocío University Hospital, Seville, Spain.

UI MeSH Term Description Entries
D007898 Leishmaniasis, Visceral A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. Black Fever,Kala-Azar,Fever, Black,Kala Azar,Visceral Leishmaniasis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D019084 Fluorescent Antibody Technique, Indirect A form of fluorescent antibody technique commonly used to detect serum antibodies and immune complexes in tissues and microorganisms in specimens from patients with infectious diseases. The technique involves formation of an antigen-antibody complex which is labeled with fluorescein-conjugated anti-immunoglobulin antibody. (From Bennington, Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984) Immunofluorescence Antibody Test, Indirect,Immunofluorescence Technique, Indirect,Fluorescent Antibody Technic, Indirect,Immunofluorescence Technic, Indirect,Indirect Fluorescent Antibody Technic,Indirect Fluorescent Antibody Technique,Indirect Immunofluorescence,Indirect Immunofluorescence Assay,Assay, Indirect Immunofluorescence,Assays, Indirect Immunofluorescence,Immunofluorescence Assay, Indirect,Immunofluorescence Assays, Indirect,Immunofluorescence Technics, Indirect,Immunofluorescence Techniques, Indirect,Immunofluorescence, Indirect,Immunofluorescences, Indirect,Indirect Immunofluorescence Assays,Indirect Immunofluorescence Technic,Indirect Immunofluorescence Technics,Indirect Immunofluorescence Technique,Indirect Immunofluorescence Techniques,Indirect Immunofluorescences

Related Publications

J A Gallardo, and J A Pineda, and J Macías, and R Torronteras, and E Lissen
May 1983, Revista clinica espanola,
J A Gallardo, and J A Pineda, and J Macías, and R Torronteras, and E Lissen
December 1996, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
J A Gallardo, and J A Pineda, and J Macías, and R Torronteras, and E Lissen
January 1986, Archives de l'Institut Pasteur d'Algerie. Institut Pasteur d'Algerie,
J A Gallardo, and J A Pineda, and J Macías, and R Torronteras, and E Lissen
October 1991, AIDS (London, England),
J A Gallardo, and J A Pineda, and J Macías, and R Torronteras, and E Lissen
April 1990, AIDS (London, England),
J A Gallardo, and J A Pineda, and J Macías, and R Torronteras, and E Lissen
June 1990, Journal of the Egyptian Society of Parasitology,
J A Gallardo, and J A Pineda, and J Macías, and R Torronteras, and E Lissen
February 1994, AIDS (London, England),
J A Gallardo, and J A Pineda, and J Macías, and R Torronteras, and E Lissen
July 2011, Ethiopian medical journal,
J A Gallardo, and J A Pineda, and J Macías, and R Torronteras, and E Lissen
April 1990, Enfermedades infecciosas y microbiologia clinica,
J A Gallardo, and J A Pineda, and J Macías, and R Torronteras, and E Lissen
January 2013, PLoS neglected tropical diseases,
Copied contents to your clipboard!